Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Photopheresis for the prevention of rejection in cardiac transplantation
Mark L. Barr
, Bruno M. Meiser
, Howard J. Eisen
, Randall F. Roberts
, Ugolino Livi
, Roberto Dall'Amico
, Richard Dorent
, Joseph G. Rogers
, Branislav Radovančević
, David O. Taylor
, Valluvan Jeevanandam
, Charles C. Marboe
, Kenneth L. Franco
, Hector O. Ventura
, Robert E. Michler
, Bartley P. Griffith
, Steven W. Boyce
, Bruno Reichart
, Iradj Gandjbakhch
Department of Medicine
Division of Cardiology
Penn State Heart and Vascular Institute
Research output
:
Contribution to journal
›
Article
›
peer-review
299
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Photopheresis for the prevention of rejection in cardiac transplantation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Acute Graft Rejection
100%
Immunosuppressive Therapy
100%
Blood Plasma
50%
Cytomegalovirus
50%
Cytomegalovirus Infection
50%
Cardiac Rejection
50%
Immunosuppression
50%
Prednisone
50%
Ciclosporin
50%
Azathioprine
50%
Hemodynamic
50%
Polymerase Chain Reaction
50%
Lymphocyte
50%
Allograft
50%
Medicine and Dentistry
Heart Transplantation
100%
Photopheresis
100%
Group Therapy
36%
Immunosuppressive Treatment
27%
Acute Graft Rejection
18%
Infection
9%
Cytomegalovirus
9%
Cytomegalovirus Infection
9%
Heart Graft
9%
Hemodynamic
9%
Allograft
9%
Cyclosporine
9%
Prednisone
9%
Heart Muscle Biopsy
9%
Azathioprine
9%
Lymphocyte
9%
Antibiotics
9%
Polymerase Chain Reaction
9%
Methoxsalen
9%
Cardiac Rejection
9%
Keyphrases
Cardiac Transplantation
100%
Therapy Groups
36%
Rejection Episodes
27%
Cytomegalovirus
18%
No Significant Difference
18%
Acute Rejection
18%
Immunosuppressive Therapy
18%
Polymerase Chain Reaction Amplification
9%
Infection Rate
9%
Cyclosporine
9%
Prophylactic Antibiotics
9%
Group 14
9%
Lymphocytes
9%
Cardiac Allograft
9%
Consecutive Days
9%
First Episode
9%
Transplantation
9%
Group 13
9%
Prednisone
9%
Pathology Department
9%
Immunomodulatory
9%
Maintenance Immunosuppression
9%
Hemodynamic Compromise
9%
Cardiac Biopsy
9%
Nursing and Health Professions
Heart Transplantation
100%
Group Therapy
36%
Immunosuppressive Treatment
27%
Acute Graft Rejection
18%
Allograft
9%
Heart Muscle Biopsy
9%
Infection
9%
Pilot Study
9%
Ciclosporin
9%
Prednisone
9%
Azathioprine
9%
Heart Graft
9%
Cytomegalovirus Infection
9%
Polymerase Chain Reaction
9%